MiR-665 aggravates heart failure via suppressing CD34-mediated coronary microvessel angiogenesis

Abstract

Our findings demonstrated that miR-665 played an important role in heart failure via damaging coronary microvessel angiogenesis, and suggested that miRNA-based therapeutics may protect against coronary microvessel dysfunction and heart failure.